Edelman-Janssen TB and MDR-TB Infographic V9

TB & MDR-TB Tuberculosis (TB) Overview TB Fast Facts 1 8.6 million people worldwide fell ill with TB in 2012 Of the world's population is infected 1.3 million people worldwide 33 with the germ that died from TB in 20121 PERCENT causes TB1 Of people infected with the germ that nd If not diagnosed and 10 causes TB have a 1.3 appropriately treated, PERCENT chance of falling ill1 MILLION 2 people ill with TB can infect 10 to 15 people over the course 8.6 of a year1 MILLION Of the world’s TB 4.4 cases occur in the PERCENT European region2 TB is the 2nd most common cause of death from infectious Of TB cases in the diseases after HIV/AIDS1 European region 87 occur in 18 high PERCENT priority countries2 What is Multi-Drug Resistant Tuberculosis (MDR-TB) and Why is it a Major Problem? MDR-TB Fast Facts 24 450,000 New global cases in 20125 Requires a 24-month regimen Strains are very difficult with up to six second-line drugs4 and costly to treat4 OVER Of MDR-TB cases occurred in China, India and the 50 5 MDR-TB PERCENT Russian Federation A form of TB caused by bacteria not responsive to the 4 standard first-line TB treatment Of MDR-TB patients Caused by inappropriate Diagnosis and treatment are worldwide were 25 enrolled in treatment or incorrect use of anti-TB drugs complex, posing a severe burden 5 and/or poor quality medicines4 on patients and health systems3,4 PERCENT in 2012 References: 1. World Health Organization. Tuberculosis: fact sheet no. 104, updated October 2013. http://www.who.int/mediacentre/factsheets/fs104/en/. Last accessed February 2014. 2. European Centre for Disease Prevention and Control, World Health Organization Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2013. http://www.euro.who.int/__data/assets/pdf_file/0004/185800/Tuberculosis-surveillance-and-monitoring-in-Europe-2013.pdf. Last accessed February 2014. 3. World Health Organization. Progress in diagnosing multi-drug resistant tuberculosis. World Tuberculosis Day, 24th March 2014. http://www.who.int/mediacentre/news/releases/2014/tb-day/en/ Last accessed June 2014. 4. TB Alliance. MDR-TB / XDR-TB. http://www.tballiance.org/why/mdr-xdr.php. Last accessed February 2014. All information current as of February 2014 5. World Health Organization. Multidrug-resistant tuberculosis (MDR-TB) October 2013 update. http://www.who.int/tb/challenges/mdr/mdr_tb_factsheet.pdf. Last accessed February 2014. Janssen Cilag International N.V. © 2014 Art accreditation: Turnhoutseweg 30 Julius Bustamante, Pajaros (4ft) B-2340 Beerse Belgium Artwork from Hospital Audiences, Inc. (HAI), a nonprofit organization that inspires healing, growth and learning through access to the arts for the culturally underserved. PHGB/NPR/0514/0018g June 2014.

Copy Link

Recommended publications

World TB Day 2001 Highlights [.Pdf]
HIGHLIGHTS_RET POUR PDF 17/10/01 11:34 Page 1 GUIDELINES for SOCIAL MOBILIZATION World TB Day 2001 Highlights Political Awareness Social Mobilization Increased Access to TB Care Sustainability Media and Community Events Best Practice HIGHLIGHTS_RET POUR PDF 17/10/01 11:34 Page 2 Preface p.5 Political Awareness Pakistan Australia United States India, Punjab Democratic Republic of the Congo Yemen he theme for World TB Day 2001— p.9 Social Mobilization T DOTS: TB cure for all—suggests that Oman we can eliminate tuberculosis from this Togo planet. A cure for all from tuberculosis (TB) is part Nigeria of the mission of the World Health Organization 3 India, Mumbai (WHO) and its Member States to allow access to The former Yugoslav Republic health services for all. of Macedonia Albania A first milestone occurred when Ministers of ACKNOWLEDGEMENT: Federal Republic of Yugoslavia Health, Development, and Finance Planning from Haiti 20 countries with the highest burden of TB met in Slovakia Amsterdam in March 2000 for the first summit THE STOP TB PARTNERSHIP WOULD LIKE TO THANK THOSE Maldives WHO TOOK THE TIME TO COMPLETE THE WORLD TB DAY against tuberculosis. 2001 QUESTIONNAIRE AND TO SUBMIT TO US REPORTS AND p.15 Increased Access Great progress has since been made as a result of ILLUSTRATIONS ABOUT THEIR ACTIVITIES. to TB Care the mobilization of the high TB burden countries India: supported by the international community as a Andhra Pradesh Rajasthan whole. This was reflected in World TB Day on 24 Tamil Nadu March 2001. Bihar This document brings to the fore the Uttar Pradesh accomplishments of World TB Day 2001, reports on Lebanon what has been achieved, underlines the remarkable Philippines events and initiatives, and analyses how the global p.19 Sustainability movement to stop TB is progressing towards its India goal of eliminating TB as a global public health Russian Federation problem.
[Show full text]
Division of Disease Control Pump Handle - 1
"I had an interview with the Board of Guardians of St. James's parish, on the evening of Thursday, 7th September, and represented the above circumstances to them. In consequence of what I said, the handle of the pump was removed on the following day." John Snow, 1855 February 2015 Topics Avian Influenza (Bird Flu) in the United States April is STD Awareness Month Find TB. Treat TB. Working together to eliminate TB. Disease Control Student Interns-Welcome! Avian Influenza (Bird Flu) in the United States In December of 2014, a handful of western U.S. states reported the identification of several high pathogenic avian influenza A H5 strains in local birds, including H5N1, H5N2 and H5N8. Since the initial reports, a total of 10 states have identified influenza A H5 strains in wild or domestic birds: Washington, California, Idaho, Oregon, Utah, Nevada, Minnesota, Missouri, Arkansas and Kansas. These H5 strains are genetically different than the H5 strains currently circulating in Asia and Africa, but are similar to strains identified this past December in British Columbia, Canada. No human cases have been associated with these U.S. avian influenza strains at this time. Avian influenza strains are not easily transmitted from birds to humans, and the risk to humans is currently considered extremely low. However, health care providers should consider avian influenza in people with influenza-like illness who have been in contact with sick or dead birds (especially poultry or water fowl) in the previous 10 days. Suspected cases of avian influenza should be reported immediately the to the North Dakota Department of Health (NDDoH) Division of Disease Control to discuss the exposure, antiviral recommendations and diagnostic testing.
[Show full text]
Advancing New Diagnostic Tests for Latent Tuberculosis Infection
International Journal of Infectious Diseases 92S (2020) S69–S71 Contents lists available at ScienceDirect International Journal of Infectious Diseases journal homepage: www.elsevier.com/locate/ijid Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis — End of the road? a b c,d e,f Peter Mwaba , Jeremiah Muhwa Chakaya , Eskild Petersen , Christian Wejse , g h,i, Alimuddin Zumla , Nathan Kapata * a Apex University School of Medicine, and UNZA-UCLMS Research and Training Program, Lusaka, Zambia b Department of Medicine, Kenyatta University, Nairobi, Kenya c Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman d Institute for Clinical Medicine, Faculty of Health Science, University of Aarhus, Aarhus, Denmark e Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark f Center for Global Health, Department of Health Services Research, Aarhus University, Aarhus, Denmark g Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom h UNZA-UCLMS Research and Training Program, University Teaching Hospital, Lusaka, Zambia i Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia A R T I C L E I N F O A B S T R A C T Article history: An estimated 1.8 billion people worldwide have a latent tuberculosis infection (LTBI), with wide Received 26 January 2020 variations in LTBI rates across countries. LTBI can be due to infection with either drug-sensitive or drug- Received in revised form 9 February 2020 resistant Mycobacterium tuberculosis (Mtb) strains.
[Show full text]
HIV-TB Comorbidity – Current Challenges and Strategies“
In cooperation with: WHO-Euro, Copenhagen; Stop TB Partnership; Stop TB Forum Germany, Berlin; Charité University Medicine, Berlin; Central Tuberculosis Research Institute, Moscow, Russia; Institute for Public Health, Ministry of Health, Moscow, Russia; Institutes or departments for Tuberculosis in Smolensk, Voronezh, Yekaterinburg, Russia; Institute for Phthisiopulmonology Chiril Draganiuc, Moldova; Institute for Tuberculosis, Tbilisi State Medical University, Georgia. Eighth Scientific Symposium on the occasion of World Tuberculosis Day 2014 Partners: Berlin Becton Dickinson Diagnostics, Hain Lifescience, vfa, Otsuka Program „HIV-TB comorbidity – current challenges and strategies“ March 20 th – 21 st , 2014 In 2014, the Koch-Mechnikov-Forum organizes the tuberculosis symposium on Langenbeck-Virchow-House, Luisenstr. 59, occasion of the World Tuberculosis Day in close cooperation with the World D – 10117 Berlin, Germany Health Summit. Its results will be reported and discussed at the next World Health Summit in Berlin, held in October 2014. in close cooperation with Content: Both, HIV and Mycobacterium tuberculosis , belong to the biggest killers and Venue: Langenbeck-Virchow-Haus, Luisenstr. 59, 10117 Berlin, Germany account for millions of deaths year by year. In recent years, coinfection with both Time: pathogens not only occurs in Subsaharan Africa, but also at tremendously Thursday, March 20, 2014: opening, first scientific day; reception; increasing speed in Eastern Europe and Central Asia where the problem of Friday, March 21, 2014: scientific symposium, second scientific day multidrug-resistant tuberculosis already makes an efficient tuberculosis control virtually impossible. Although the development of new strategies, new diagnostic Certification: tools and new drugs to fight tuberculosis is currently speeding up, HIV-TB acquirable: Continuing education credit points 12 (Category A).
[Show full text]
World TB Day Reminds Us to Remain Vigilant
March 21, 2013 Contact: Tom Schlueter (630) 444-3098 (630) 417-9729 cell World TB Day reminds us to remain vigilant On World Tuberculosis Day, March 24, the Kane County Health Department is reminding people that, although the illness is not as common as it once was, it is still circulating around the world. World TB Day commemorates the day in 1882 when Dr. Robert Koch announced his discovery of the bacteria that causes TB, Mycobacterium tuberculosis. TB has been a scourge across human history, and the discovery of the causative agent by Dr. Koch began the modern public health efforts to control and now, eliminate, TB. The Kane County Health Department has been battling an outbreak of TB at a local homeless shelter since 2007. While TB cases statewide in Illinois have reached record lows, a total of 45 cases of active TB have been linked to the shelter outbreak. Health Department nurses visit the shelter daily as the investigation continues. Tuberculosis is a contagious and potentially life-threatening disease that is transmitted from person to person through the air when a person with active TB coughs or sneezes. While it can affect any part of the body, such as the brain, kidneys or spine, tuberculosis usually affects the lungs. General symptoms may include fatigue, weight loss, fever and night sweats. When tuberculosis attacks the lungs, symptoms can include a persistent cough that sometimes produces blood and chest pains. While tuberculosis is usually curable, a person with the disease must faithfully adhere to prescribed drug therapy for six months or longer.
[Show full text]
Igras: Among the Blind the One-Eyed Is King 2Nd Symposium About Igras Special Session World Tuberculosis Day
IGRAs: Among the blind the one-eyed is king 2nd symposium about IGRAs Special Session World Tuberculosis Day. 21st of March 2013 Barcelona. Catalonia. Spain J. Domínguez Servei Microbiologia. Institut d’Investigació Germans Trias i Pujol Badalona, Barcelona. ([email protected]) Brief history 2000 Nil Avian Human Mitogen Control PPD PPD Control Stimulating antigens: human PPD and avian PPD Brief history T-SPOT.TB Tuberculin skin testing QuantiFERON-TB Gold In Tube 2002 Moving LTBI diagnosis from clinical departments to laboratory. Comparison between TST and IGRAs Domínguez J. Actas Derm-Sifil. 2012 Domínguez J. 2009 First day T-SPOT.TB QFN-G-IT Exp Rev Resp Med. Collection of blood sample (8ml) Collection of blood sample and centrifugation (3ml) in QFN tubes containing MTB antigens Isolation of PBMCs and washing hands No Count PBMCs using a - on time for 1 sample for 1 on time on time - counting chamber on time for 20 samples 20 on time for - Addition of 250,000 cells per well 4 h hands 4 with the MTB specific antigens 1/2 hour (h) hands (h) hour 1/2 Overnight incubation Overnight incubation Second day Centrifugation of tubes to harvest the IFN-gamma released samples 20 to 1 for 1 h hands h 1 on for time ELISPOT ELISA - - on time 1 to 20 samples samples 20 to 1 1 h hands h 1 Count spots by naked eye or using a plate reader Read the concentration of IFN-gamma by means of an automated reader Correlation with latent TB infection Domínguez J. CVI. 2008 BCG vaccination effect Domínguez J.
[Show full text]
Discurso De La
Address of Dr. Carissa F. Etienne at the World Tuberculosis Day commemoration “Stop TB in our lifetime. A Shared Commitment” Washington D.C., March 19, 2013 Good morning. We mark World Tuberculosis Day today in commemoration of Dr. Robert Koch, who, on the 24th of March 1882, announced to the world the discovery of the disease’s causative agent, the “tubercle bacillus.” Although 130 years have come and gone since then, tuberculosis continues to be responsible for pain and death across the globe, not excluding the Americas. This year we celebrate World TB Day with the slogan “STOP TB IN OUR LIFETIME. A SHARED COMMITMENT”. This means commitment by all, as affected communities and partners in combating the disease embrace the goal of “ZERO TB DEATHS.” Great progress in controlling tuberculosis has been made in the Americas – so much so that the Millennium Development Goal targets for TB have been met ahead of time, with a stable 3% annual reduction in the incidence of the disease, a 61% reduction in mortality, and a 62% reduction in prevalence between 1990 and 2011. These are major achievements; however, they do not extend to the most vulnerable populations, such as ethnic minorities, and our poor and marginalized populations living in cities. We currently have opportunities, since our Region is experiencing sustained economic growth, with stable governments and major advances in development that have positive impacts for health – as the increased life expectancy of the Region’s inhabitants reflects. The recognition and addressing of the social determinants of health through harmonized and coordinated work across different political and social sectors is allowing better living conditions for the most unprotected populations.
[Show full text]
Biomérieux Announces the CE Marking of TB IGRA® Test on VIDAS®
bioMérieux announces the CE marking of TB IGRA® test on VIDAS® Marcy l’Etoile, France – March 24th, 2021 – Today marks World Tuberculosis (TB) Day and bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated test VIDAS® TB IGRA (Interferon-Gamma Release Assay) to diagnose latent TB infection. Tuberculosis continues to be a major global health problem. With 10 million new active cases and 1.4 million related deaths worldwide in 20191, TB remains an important cause of mortality from a single infectious disease. It is estimated that a fourth of the global population is infected with Mycobacterium tuberculosis, the bacteria responsible for TB disease. In most cases (90-95%), people with healthy immune systems can control the infection without developing the active disease: this is called “Latent Tuberculosis Infection” (LTBI). The remaining infected people (5-10%), will develop active TB disease (aTB), making them sick as well as infectious to others. “Despite all efforts, tuberculosis has not been eradicated and remains a significant health problem for a large proportion of the world’s population, especially in low- and middle-income countries. Diagnosing people who have latent TB infection is an important tool for global TB control. Detecting and then following or treating people with latent TB infection can help in preventing their progression to active disease, which would make them sick and also infectious to others.” said Mark Miller, Executive Vice President and Chief Medical Officer, bioMérieux. There is no single gold standard for diagnosing LTBI. Current diagnostic tools for LTBI include a detailed clinical history of exposure to TB, the tuberculin skin test (TST) or an IGRA test, which are indirect diagnostic methods based on the host immune response to the pathogen2.
[Show full text]
Timo Ulrichs, KMF, and Akkon University for Human Sciences Berlin
9th Scientific Symposium on the occasion of World Tuberculosis Day 2015 Berlin Preliminary Program Tuberculosis control and prevention – Vaccination, prophylaxis and public health interventions Aim and content Together with HIV/AIDS and malaria, tuberculosis still belongs to the three big killers of humanity, accounting for approximately 1.5 million deaths per year. Although the millennium development goal number 6 aimed at reducing TB numbers by 50% in 2015 compared to the situation in 1990, TB is still a global health emergency. Especially in the WHO European Region, we are far away from reaching MDG No. 6, and this has to be discussed in detail after analyzing the situation in 2015, the endpoint of the MDG time frame. Two major obstacles prevented us from improving the situation: increasing numbers in multidrug-resistant cases and HIV-TB comorbidity. Successful treatment of these cases becomes more and more impossible. Thus, preventive strategies and most of all an efficient vaccine are urgently needed. The 9th Scientific Symposium of the Koch-Mechnikov-Forum on the occasion of World Tuberculosis Day 2015 will therefore focus on current developments in vaccine research, preventive and public health measures in TB control and overall strategies to efficiently fight the disease. Organization The 9th Scientific TB Symposium is co-organized by the Koch-Mechnikov-Forum (KMF) and the Tuberculosis Vaccine Initiative (TBVI). 1 Scientific organizing committee: Erna Balk, TBVI, Lelystad, The Netherlands Executive Director, TBVI Helmut Hahn, KMF Berlin Timo Ulrichs, KMF, and Akkon University for Human Sciences Berlin Project coordination: Anastasia Stepanovich, KMF, Langenbeck-Virchow-Haus, Luisenstraße 59, 10117 Berlin, Germany; Tel.: +49-30-2345-7722; [email protected] Venue KARL-STORZ GmbH & Co.
[Show full text]
How to Ensure Political Commitment for Mdr Tb Management
HOW TO ENSURE POLITICAL COMMITMENT FOR MDR TB MANAGEMENT César Bonilla MD. REGION OF THE AMERICAS TUBERCULOSIS, YEAR 2004 Canada 9% USA Haiti Dom. Rep. Mexico 6.8% Honduras 75% Ecuador Total: 247,387 Peru Bolivia Brazil Peru 50% Nicaragua Brazil Source: WHO Report 2006. Global Tuberculosis Control. Surveillance, Planning, Financing BASIC PRINCPLES IN MDR-TB MANAGEMENT 1. To establish a National TB Program that is efficient, effective and integrated into general health care services 2. To assure free access to quality medication (through application to the Green Light Committee). 3. To coordinate with the community and local governments to establish strategies that help ensure treatment adherence of the TB patient. 4. To provide free access to drug sensitivity tests. 5. To design an appropriate TB treatment regimen for the patient. POSITIONING THE NATIONAL TB CONTROL PROGRAM AS A FUNDAMENTAL ELEMENT IN ENSURING POLITCAL COMMITMENT TECHNICAL EFFICIENCY IN MDR-TB MANAGEMENT 1. Clear objectives for the 6. Coordination and strategic short, medium, and long partnerships that facilitate term. a leadership role of MDR-TB 2. Clear components that management in the health improve processes care reform process, especially in regards to 3. Consistency in application Cross-sectional decentralization. of the DOTS strategy Approach: 4. Transparency in decision- 7. Organizational aspects: POLITCAL making and in the use of Laboratory conditions COMMITTMENT resources Treatment strategy 5. Work in a multidisciplinary Information system and team at different levels of data management health care. Supervision and monitoring of patient care PRODUCTS OF THE APPROPRIATE APPLICATION OF THE BASIC PRINCIPLES IN MDR-TB MANAGEMENT 1.
[Show full text]
World Tuberculosis Day 2019: More Needs to Be Done to #Endtb by 2030
World Tuberculosis Day 2019: more needs to be done to #EndTB by 2030 March 24 marks World Tuberculosis Day. In 1882 on this day, Dr Robert Koch announced the discovery of the bacteria that causes tuberculosis (TB), and paved the way towards diagnosing and treating it. Thanks to years of efforts, better diagnostics tools and more effective treatment regiments give hope to TB patients, their families and communities. Ahead of World Tuberculosis Day, the Commission announced: "On the World Tuberculosis Day taking place on Sunday 24 March, the European Commission aims to raise awareness about the burden and prevention of tuberculosis as well as to mobilise efforts in the fight against the disease. Although every hour, 30 people are diagnosed with tuberculosis in Europe, overall, the decrease in tuberculosis cases observed in most countries is reassuring. Still, sustained efforts are needed to reach the 80% reduction target in the tuberculosis incidence rate in 2030 compared to 2015. Vytenis Andriukaitis, European Commissioner for Health and Food Safety, said: "On World Tuberculosis Day, my thoughts are with all the people who are suffering from the deadliest infectious disease in the world. The EU Member States have reiterated their commitment to end the tuberculosis epidemic by 2030 at a high-level United Nations meeting in September 2018. Therefore, I call on leaders in the EU and beyond, to boost their public health measures against tuberculosis hand in hand with other sectors. Existing tools and good practices should be better implemented, and focus on people's needs. Together with our agencies, the Commission will continue to support such efforts from different policy angles including funding, research, fight against antimicrobial resistance, prevention, early diagnosis and linkage to treatment and care.
[Show full text]
STANDARD DEVIATIONS: Keeping a Perspective
STANDARD DEVIATIONS: Keeping a Perspective Greetings, Coronavirus is all the rage. It dominates our news, our conversations, and our lives. But in terms of consequence to our health and the world, coronavirus is just another drop in the bucket. Tomorrow is World Tuberculosis Day. Each year, we recognize World TB Day on March 24. This annual event commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis (TB). Up to 13 million people in the United States have latent TB infection. Here is a respiratory disease that dwarfs COVID-19. This bacterial malady is spread from person to person through the air. TB usually affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine. The TB bacteria are put into the air when a person with TB disease of the lungs or throat coughs, sneezes, speaks, or sings. People nearby may breathe in these bacteria and become infected. Sound familiar? Worldwide, 10 million people acquired TB in 2018 (last year of stats) and 1.5 M died. Nearly 500,000 cases are drug-resistant type TB. The common tests we utilize these days are the tuberculin skin test that we geezers recall being administered each year by our employee health nurse and read a few days later with a ruler, and the standard now, the QuantiFERON®–TB Gold In-Tube test (QFT–GIT). We also perform a bunch of lab work on these patients. The Acid-Fast Bacillus (AFB), Nucleic Acid Amplification Test (NAAT), and sputum culture all add to our workload.
[Show full text]